LTS Lohmann Therapie-Systeme AG
First product based on LTS’ Sorrel(TM) wearable drug delivery platform launched in the US
mehr
Storys zum Thema Gesundheit / Medizin
- Sprache:
- Medien:
- Zeitraum:
- Zeitraum:01.01.2023 - 11.08.2025
Biomay Announces its Successful Support of Approval of First CRISPR/Cas9-based Therapy
mehrSHL Medical partners with SteriPack Group to set up final assembly service
mehrLTS Lohmann Therapie-Systeme AG
LTS receives $4.3 Million grant for the development of contraceptive Microneedle Array Patches
mehrLTS Lohmann Therapie-Systeme AG
LTS receives grant of $1.2 Million to support the development of thermostable mRNA formulations for Microneedle Array Patches
mehrSHL Medical achieves EcoVadis® Silver Medal and sets ambitious science-based climate targets
mehrBiomay Announces Expansion of GMP-Facilities to Offer mRNA Manufacturing and Aseptic Filling Services
mehrSuperVista AG expands strategically with new 360-degree B2B offering for the entire ophthalmic optics sector
mehrSHL Medical and Lifecore Biomedical enter co-marketing partnership agreement
mehrOD-OS GmbH at ESCRS 2023: Recent MDR certification of Navilas® underlines its advanced standard in retina lasers and opens path to new developments
mehrGerman Bionic Debuts Groundbreaking Power Suit for Nursing and Care Professionals in North America
mehrRHEACELL announces “First Patient In”: EB-Haus in Salzburg, Austria starts pivotal study for stem cell therapy for severe forms of Epidermolysis bullosa that is longed for by those affected
mehrThe world's first Extended Isolated Stopflow Limb Infusion (EISLI) to treat osteosarcoma results in complete remission
mehrBlood Donation Day at R-Biopharm: Employees Help Save Lives
mehrBreakthrough - EUR 50 million investment for start-up BrainRepair UG / Pivotal trial on stem cell treatment for brain damage in newborns fully funded
mehr
Vorherige12